Is Regorafenib produced in India?

Regorafenib(Regorafenib)There is a version produced in India, which belongs to the scope of generic drugs. Its pharmaceutical ingredients are basically the same as those of the original drug of Regorafenib, but the manufacturer is different. , Different production specifications lead to different prices. Common Indian manufacturers include NATCO of India. The price of each box of 40mg*28 tablets may be around 1,680 RMB (the price may fluctuate due to the exchange rate). If the patient needs this medicine, it needs to be purchased through formal channels.

Regofenib is a multi-target inhibitor used to treat certain advanced cancers, includingmetastatic colorectal cancer (CRC), locally advanced, unresectable or metastatic gastrointestinal stromal tumor ( pan>GIST) and hepatocellular carcinoma (HCC),Patients may have been treated with other drugs, such as imatinib sulfonate and sunitinib malate, which work by inhibiting angiogenesis and inhibiting tumor cell proliferation.

RegofenibThe original drug has been launched in China and has entered the scope of Class B medical insurance. Reimbursement is limited to patients who meet the indications. SpecificationThe price of each box of 40mg*28 tablets is around RMB 5,000. The reimbursement ratio is different in different regions, and the price after reimbursement is different. The Turkish version of regorafeniboriginal drug specifications 40mg*28 tablets sold overseas is priced around RMB 6,400 per box (the price may fluctuate due to exchange rates). There are also generic regorafenib drugs produced in other countries, and their drug ingredients are basically the same as those of the original drug. For example, the price of a box of 40mg*90 tablets produced by a Bangladesh pharmaceutical factory is around RMB 2,900 (the price may fluctuate due to exchange rates).